RadOnc on the Run

RadOnc on the Run
  • 0.0 (0)
  • LIFE SCIENCES

In RadOnc on the Run, ONCOLOGY® Editor-at-Large Brandon Mancini, MD, MBA, FACRO, speaks to the latest advances and research dedicated to elevating the quality of radiation oncology care. Discussions with the multidisciplinary care team and others across the oncology continuum will explore practical considerations for optimizing the use of radiotherapy and improving patient outcomes.

Episodes

  1. Screening, Prevention, and Intervention on Cervical Cancer Awareness Month

    2D AGO

    Screening, Prevention, and Intervention on Cervical Cancer Awareness Month

    In observance of Cervical Cancer Awareness Month in January, host Brandon Mancini, MD, MBA, FACRO, convened with Melissa Wylie Brackmann, MD, to highlight various advancements in cervical cancer prevention and treatment as well as critical takeaways for elevating the quality of patient care. The experts touched upon advancements in screening, preventative vaccination, surgical and systemic modalities, and other key areas in the field. Brackmann began by noting how cervical cancer may take a long time to develop, and that detecting high-risk pre-cancers through screening may help prevent the formation of more advanced diseases. Given cervical cancer’s association with HPV infections, the discussion also focused on the role that HPV vaccination can play in limiting the risk of cervical cancer. According to Brackmann, other potential advancements in the cervical cancer space pertain to targeted therapies, which include immunotherapeutic agents like pembrolizumab (Keytruda) and antibody drug conjugates like tisotumab vedotin-tftv (Tivdak). The experts also spoke about considerations for counseling patients on the safety of radiation and surgical modalities like hysterectomy while balancing realism with hope when developing a personalized treatment plan. Brackmann concluded by emphasizing the importance of patients undergoing screening for potential disease and seeking resources related to other preventative strategies. “There is a tremendous amount of hope, in the community and amongst [gynecologic] oncologists, for this cancer to be better treated and better managed,” Brackmann stated during the discussion. “[It] is often curable in early stages [while] having less long-term [adverse] effects from our chemotherapies, our radiations, and our surgeries.” Mancini is director at Bold Advanced Medical Future Health, clinical associate professor in the Department of Radiology at Michigan State University College of Human Medicine, and editor-at-large for the RadOnc Review, a supplement of the journal ONCOLOGY®. Brackmann is an assistant professor of Gynecologic Oncology at the University of Michigan Medical School.

    34 min
  2. Taking the First Steps Beyond the Starting Line With RadOnc on the Run

    JAN 20

    Taking the First Steps Beyond the Starting Line With RadOnc on the Run

    As part of ushering in a new podcast series on CancerNetwork®, Brandon Mancini, MD, MBA, FACRO, introduced himself as the host of RadOnc on the Run, a program dedicated to discussing critical advances and considerations in radiation oncology care and research. He outlined the podcast’s objective of serving as an educational resource among radiation oncologists in the field, describing aims such as reviewing the latest data to emerge from key oncology conferences and meetings, as well as strategies for collaborating with members of a multidisciplinary team. Additionally, the program looks to share ideas for safely and efficiently administering radiation to patients by touching upon topics like billing, policy, and mitigating potential adverse effects during treatment. Mancini first discussed how his background and prior work led to his current roles in the field. He is currently the director at BAMF Health, clinical associate professor in the Department of Radiology at Michigan State University College of Human Medicine, and editor-at-large for The RadOnc Review, a supplement of the journal ONCOLOGY®.  On top of the new podcast, Mancini emphasized the RadOnc Review as a new resource that may fill an informational gap in the radiation oncology space. The supplement, which will be PubMed-indexed under the journal ONCOLOGY and published on a quarterly basis, is currently accepting all major manuscript types. As part of RadOnc on the Run, Mancini detailed the goal of keeping listeners up to date with techniques, challenges, and other developments regarding the radiotherapeutic management of cancer. Emphasizing expert-led, high-level insights, the podcast will feature perspectives from specialists in surgical oncology, gynecologic oncology, patient advocacy, and other disciplines to explore how widely applicable radiation therapy can be. From covering benign conditions like osteoarthritis to discussing novel modalities such as MRI-guided radiation therapy, RadOnc on the Run will deliver comprehensive conversations on the most salient topics in radiation oncology.

    10 min
  • 2 Episodes

About

In RadOnc on the Run, ONCOLOGY® Editor-at-Large Brandon Mancini, MD, MBA, FACRO, speaks to the latest advances and research dedicated to elevating the quality of radiation oncology care. Discussions with the multidisciplinary care team and others across the oncology continuum will explore practical considerations for optimizing the use of radiotherapy and improving patient outcomes.

Information

  • Creator
    RadOnc on the Run
  • Years Active
    2K
  • Episodes
    2
  • Rating
    Clean
  • Show Website
    RadOnc on the Run